Skip to main content
Skip to main navigation menu
Skip to site footer
Open Menu
Journal of Commercial Biotechnology
Submissions
Subscribe
Current
Archives
Announcements
Search
About
About the Journal
Editorial Team
Privacy Statement
Contact
Search
Register
Login
Home
/
Archives
/
Vol. 26 No. 4 (2021): Vol. 26 No. 4 (2021)
Vol. 26 No. 4 (2021): Vol. 26 No. 4 (2021)
Published:
2021-12-23
Editorial
A Note From the Editor in Chief
Arthur A Boni
Requires Subscription or Fee
PDF
(USD 25)
Articles
The Role of the Biotechnology Industry in Addressing Health Inequities in Africa: Strengthening the Entire Health Care Value Chain
Stephen M. Sammut
Requires Subscription or Fee
PDF
(USD 25)
Considerations for Potential Global Expansion of Serum Institute of India
Veena Somasundaram, Peter Soukas, Jenish Patel, Steven Ferguson
Requires Subscription or Fee
PDF
(USD 25)
Drug Repositioning as a Pharmaceutical Strategy: The Obvious Benefits are Real but Beware of Pitfalls That May be Less Apparent.
Andrew G. Reaume
Requires Subscription or Fee
PDF
(USD 25)
Strategic Alliance and Acquisition Performance: Impact of Interfirm Synergies and Motives in the Bio-Pharmaceutical Industry
Thani Jambulingam, Todd Saxton
Requires Subscription or Fee
PDF
(USD 25)
Australian Biotechnology: A 10-Year Study of Investor Performance
Peter L. Molloy , Lester W. Johnson, Michael Gilding
Requires Subscription or Fee
PDF
(USD 25)
From the Boardroom
A conversation on accelerating innovation in biopharma and life sciences through global collaboration and alliances
Arthur A Boni, Peter L. Molloy
Requires Subscription or Fee
PDF
(USD 25)
about
Subscription Options
Subscription
Login to access subscriber-only resources.
Make a Submission
Make a Submission
Current Issue